Extends Waystar’s AI Leadership Into Clinical Intelligence Software, Unlocking Greater Value for Clients and Shareholders Highly Recurring Subscription-Based Business Projected…
CULVER CITY, Calif.–(BUSINESS WIRE)–ImmunityBio, Inc. (NASDAQ: IBRX), a leading immunotherapy company, today announced the Michael E. DeBakey Department of Veterans…